
    
      The study was to retrospectively analyse the efficacy and safety of percutaneous left atrial
      appendage (LAA) closure using the LAmbre (Lifetech Scientific Co., Ltd., Shenzhen, China) in
      our center from April 2014 to November 2015. 89.4% has finished the 12-month esophageal
      ecllocardiogrhy (TEE) examination. The average followup was 2-years.
    
  